Literature DB >> 19502100

Serum C-reactive protein as a prognostic indicator in patients with oral squamous cell carcinoma.

Sunil D Khandavilli1, Padraig O Ceallaigh, Christopher J Lloyd, Rhiannon Whitaker.   

Abstract

Preoperative elevation of serum C-reactive protein (CRP) has been demonstrated as a prognostic indicator in oesophageal, gastric and colorectal cancer. This study was designed to establish if elevated preoperative levels of serum CRP could predict the prognosis of patients treated with primary surgery for oral squamous cell carcinoma (SCC). Sixty patients with oral SCC who were treated by primary surgery and microvascular free flap reconstruction, were included in the study. The relation between preoperative levels of serum CRP, clinicopathological features and patient prognosis was determined. This study showed using bivariate analysis (p=0.003) and multivariate analysis (p<0.001) that a raised preoperative CRP was associated with worse overall survival. Tumour size and stage when combined with CRP levels increases the predictive power of this indicator.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19502100     DOI: 10.1016/j.oraloncology.2009.03.015

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  32 in total

1.  C-reactive protein level predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy.

Authors:  Yue-Can Zeng; Ming Xue; Feng Chi; Zhao-Guo Xu; Guo-Liang Fan; Rong Wu; Yu-Chen Fan; Wen-Zhao Zhong; Si-Liang Wang; Xiao-Ye Zhang; Li-Na Wu; Xiao-Dong Chen; Xue-Ying Jin; Qiong-Yu Duan; Ru Xu; Wei Chen; Hao-Chu Qian; Yu-Ping Xiao
Journal:  Tumour Biol       Date:  2012-02-07

2.  High neutrophil-to-lymphocyte ratio is an independent marker of poor disease-specific survival in patients with oral cancer.

Authors:  Christos Perisanidis; Gabriela Kornek; Paul W Pöschl; Daniel Holzinger; Katharina Pirklbauer; Christian Schopper; Rolf Ewers
Journal:  Med Oncol       Date:  2013-01-06       Impact factor: 3.064

3.  Primary radiotherapy or postoperative radiotherapy in patients with head and neck cancer: Comparative analysis of inflammation-based prognostic scoring systems.

Authors:  Edgar Selzer; Anja Grah; Gregor Heiduschka; Gabriela Kornek; Dietmar Thurnher
Journal:  Strahlenther Onkol       Date:  2015-01-13       Impact factor: 3.621

4.  Arginase and C-reactive protein as potential serum-based biomarker of head and neck squamous cell carcinoma patients of north east India.

Authors:  Biswadeep Choudhury; Shilpee Srivastava; Haider H Choudhury; Alokananda Purkayastha; Sumita DuttaGupta; Sankar Kumar Ghosh
Journal:  Tumour Biol       Date:  2014-04-09

5.  Clinical relevance of a new pre-treatment laboratory prognostic index in patients with oral squamous cell carcinoma.

Authors:  M Grimm; M Lazariotou
Journal:  Med Oncol       Date:  2011-08-19       Impact factor: 3.064

6.  Cervical lymphadenopathy: study of 251 patients.

Authors:  Basel Al Kadah; Hristo Hristov Popov; Bernhard Schick; Dirk Knöbber
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-10-08       Impact factor: 2.503

7.  Neutrophil-to-lymphocyte ratio as a prognostic factor for pharyngocutaneous fistula after total laryngectomy.

Authors:  F T Aires; R A Dedivitis; M A V Kulcsar; D M Ramos; C R Cernea
Journal:  Acta Otorhinolaryngol Ital       Date:  2018-02       Impact factor: 2.124

8.  C-reactive protein levels: a prognostic marker for patients with head and neck cancer?

Authors:  Astrid L Kruse; Heinz T Luebbers; Klaus W Grätz
Journal:  Head Neck Oncol       Date:  2010-08-02

9.  Prognostic impact of pretherapeutic laboratory values in head and neck cancer patients.

Authors:  Franziska Peter; Claus Wittekindt; Mira Finkensieper; Michael Kiehntopf; Orlando Guntinas-Lichius
Journal:  J Cancer Res Clin Oncol       Date:  2012-09-25       Impact factor: 4.553

10.  Evaluation of the prognostic utility of the hemoglobin-to-red cell distribution width ratio in head and neck cancer.

Authors:  Tristan Tham; Caitlin Olson; Michael Wotman; Sireesha Teegala; Julian Khaymovich; Josephine Coury; Peter Costantino
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-09-24       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.